AGING: KEEPING YOUR MORTALITY AT BAY
Richard E Ya Deau M.D. FACS, FACHE (HON)
Studying populations without either cancer or
- diabetes. But:
These genetic predeterminants also produce profound dwarfism! Ecuadoreans with “Laron Syndrome” will inform us about both the genetics of these problems and the need for caution to avoid unintended consequences.
What is Science Doing?
Valter Longo, University of Southern California Online journal “Science Translational Medicine” February 17,2011
The search for proteins that improve memory led to one “IGF-II” which improves “declarative memory.” When blocked, memory was destroyed.
What is Science Doing?
Cristina Alberini Mount Sinai School of Medicine Nature, January 2011
An Immune Aid for Aging or “Increasing health span versus lifespan”
What is Science Doing?
Edward Goetzi University of California, San Francisco. Clinical Immunology, January 2011 Edward Goetzi University of California, San Francisco. Clinical Immunology, January 2011
Lenalidomide:
- Increases T cells and their ability to migrate.
(IL-2 and IFN-gamma a cytokine)
- The levels of the active cytokines in treated
adults equals those of young adults Lenalidomide:
- Increases T cells and their ability to migrate.
(IL-2 and IFN-gamma a cytokine)
- The levels of the active cytokines in treated